Quantitative analysis of the impact of membrane permeability on intestinal first-pass metabolism of CYP3A substrates

Biopharm Drug Dispos. 2024 Feb;45(1):3-14. doi: 10.1002/bdd.2379. Epub 2023 Dec 12.

Abstract

The aim of this study was firstly to investigate the effect of membrane permeability on the intestinal availability (Fg ) of 10 cytochrome P450 3A4 substrates with differing permeability (Papp ) and metabolic activity (CLint ) using Madin-Darby canine kidney II (MDCKII) cells expressing human CYP3A4 (MDCKII/CYP3A4 cells), and secondly to confirm the essential factors by simulations. A membrane permeation assay using MDCKII/CYP3A4 cells showed a significant correlation between human intestinal extraction ratio (ER) (Eg (=1 - Fg )) and in vitro cellular ER (r = 0.834). This relationship afforded better predictability of Eg values than the relationship between Eg and CLint,HIM values obtained from human intestinal microsomes (r = 0.598). An even stronger correlation was observed between 1 - Fa ·Fg and ER (r = 0.874). Simulation with a cellular kinetic model indicated that ER is sensitive to changes of PSpassive and CLint values, but not to the intracellular unbound fraction (fu,cell ) or P-gp-mediated efflux (PSP - gp ). It may be concluded that, based on the concentration-time profile of drugs in epithelial cells, transmembrane permeability influences Fg (or ER) and drug exposure time to metabolizing enzymes for P450 substrate.

Keywords: CYP3A4; first-pass metabolism; intestinal absorption; intestinal metabolism; modeling & simulation.

MeSH terms

  • Animals
  • Cell Membrane Permeability
  • Cytochrome P-450 CYP3A* / metabolism
  • Dogs
  • Humans
  • Intestinal Absorption*
  • Intestines
  • Permeability

Substances

  • Cytochrome P-450 CYP3A